Riana Cockeran

Riana Cockeran

Auto-generated profile, based on publicly available information

Riana Cockeran

Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; and Department of Immunology, Tshwane Academic Division, National Health Laboratory Services, Pretoria

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2013 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
HSHelen Steel
Helen Steel
RCRiana Cockeran
Riana Cockeran
RARONALD ANDERSON
RONALD ANDERSON
CFCharles Feldman
Charles Feldman
Community-acquired pneumonia (CAP) remains a leading cause of morbidity and mortality among the infectious diseases. Despite the implementation of national pneumococcal polyvalent vaccine-based immunisation strategies targeted at high-risk groups,Streptococcus pneumoniae(the pneumococcus) remains the most common cause of CAP. Notwithstanding the HIV pandemic, major challenges confronting the control of CAP include the range of bacterial and viral pathogens causing this condition, the ever-increasing problem of antibiotic resistance worldwide, and increased vulnerability associated with steadily aging populations in developed countries. These and other risk factors, as well as diagnostic strategies, are covered in the first section of this review. Thereafter, the review is focused on the pneumococcus, specifically the major virulence factors of this microbial pathogen and their role in triggering overexuberant inflammatory responses which contribute to the immunopathogenesis of invasive disease. The final section of the review is devoted to a consideration of pharmacological, anti-inflammatory strategies with adjunctive potential in the antimicrobial chemotherapy of CAP. This is focused on macrolides, corticosteroids, and statins with respect to their modes of anti-inflammatory action, current status, and limitations.

27 June 2012 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
NMN. Daphney Mutepe
N. Daphney Mutepe
RCRiana Cockeran
Riana Cockeran
HSHelen Steel
Helen Steel
ATAnnette J. Theron
Annette J. Theron
TMTim J. Mitchell
Tim J. Mitchell
RARONALD ANDERSON
RONALD ANDERSON
Although the well-recognised predisposition of cigarette smokers to the development of severe pneumococcal disease may be attributable to impairment of local host defences, less is known about the direct effects of smoke exposure on airway pathogens, or their virulence factors. In the current study, we have investigated the effects of cigarette smoke condensate (CSC) on biofilm formation byStreptococcus pneumoniae, and on the pore-forming activity of its major toxin, pneumolysin.Biofilm formation following exposure of the pneumococcus to CSC (20–160 μg·mL−1) was measured using a crystal violet-based spectrophotometric procedure, while the pore-forming activity of recombinant pneumolysin was determined by a fura-2/acetoxymethyl ester-based spectrofluorimetric procedure to monitor the uptake of extracellular Ca2+by isolated human neutrophils.Exposure of the pneumococcus or pneumolysin to CSC resulted in significant dose-related augmentation of biofilm formation (p≤0.05 at 80 and 160 μg·mL−1) and substantial attenuation of the pore-forming interactions of pneumolysin, respectively.Augmentation of biofilm formation and inactivation of pneumolysin as a consequence of smoking are likely to favour microbial colonisation and persistence, both being essential precursors of pneumococcal disease.

25 May 2010 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
RARONALD ANDERSON
RONALD ANDERSON
GTGregory Tintinger
Gregory Tintinger
RCRiana Cockeran
Riana Cockeran
MPMoliehi Potjo
Moliehi Potjo
CFCharles Feldman
Charles Feldman
In general antibiotics interact cooperatively with host defences, weakening and decreasing the virulence of microbial pathogens, thereby increasing vulnerability to phagocytosis and eradication by the intrinsic antimicrobial systems of the host. Antibiotics, however, also interact with host defences by several other mechanisms, some harmful, others beneficial. Harmful activities include exacerbation of potentially damaging inflammatory responses, a property of cell-wall targeted agents, which promotes the release of pro-inflammatory microbial cytotoxins and cell-wall components. On the other hand, inhibitors of bacterial protein synthesis, especially macrolides, possess beneficial anti-inflammatory/cytoprotective activities, which result from interference with the production of microbial virulence factors/cytotoxins. In addition to these pathogen-directed, anti-inflammatory activities, some classes of antimicrobial agent possess secondary anti-inflammatory properties, unrelated to their conventional antimicrobial activities, which target cells of the innate immune system, particularly neutrophils. This is a relatively uncommon, potentially beneficial property of antibiotics, which has been described for macrolides, imidazole anti-mycotics, fluoroquinolones, and tetracyclines. Although of largely unproven significance in the clinical setting, increasing awareness of the pro-inflammatory and anti-inflammatory properties of antibiotics may contribute to a more discerning and effective use of these agents.

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RCRiana Cockeran
Riana Cockeran
JHJenny A. Herbert
Jenny A. Herbert
TMTimothy J. Mitchell
Timothy J. Mitchell
TDThérèse Dix-Peek
Thérèse Dix-Peek
CDCaroline Dickens
Caroline Dickens
CFCharles Feldman
Charles Feldman
Alterations in whole genome expression profiles following exposure of the pneumococcus (strain 172, serotype 23F) to cigarette smoke condensate (160 μg/mL) for 15 and 60 min have been determined using the TIGR4 DNA microarray chip. Exposure to CSC resulted in the significant (P<0.014–0.0006) upregulation of the genes encoding the two-component regulatory system 11 (TCS11), consisting of the sensor kinase,hk11, and its cognate response regulator,rr11, in the setting of increased biofilm formation. These effects of cigarette smoke on the pneumococcus may contribute to colonization of the airways by this microbial pathogen.

1 October 2011 in Vaccine
Verified
Journal Article
Closed access
RCR. Cockeran
R. Cockeran
HSHelen Steel
Helen Steel
ATA.J. Theron
A.J. Theron
TMT.J. Mitchell
T.J. Mitchell
CFC. Feldman
C. Feldman
RARONALD ANDERSON
RONALD ANDERSON

1 January 2009 in Journal of Inflammation
Verified
Journal Article
Open access
PDF file
GTGregory R Tintinger
Gregory R Tintinger
ATAnnette J Theron
Annette J Theron
HSHelen Steel
Helen Steel
RCRiana Cockeran
Riana Cockeran
LPLynette Pretorius
Lynette Pretorius
RARONALD ANDERSON
RONALD ANDERSON
The role of protein kinase C (PKC) in regulating the activity of phospholipase C (PLC) in neutrophils activated with the chemoattractant, platelet-activating factor (PAF, 20 and 200 nM), was probed in the current study using the selective PKC inhibitors, GF10903X (0.5 - 1 μM) and staurosporine (400 nM).